Plentz Ruben R, Malek Nisar P
Department of Internal Medicine I, Medical University Hospital, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.
Department of Internal Medicine I, Medical University Hospital, Otfried-Müller-Str. 10, 72076 Tübingen, Germany.
Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):245-52. doi: 10.1016/j.bpg.2015.02.001. Epub 2015 Feb 14.
Cholangiocarcinoma (CCA) is the second most common primary liver tumour. Intra-hepatic CCA develops within the liver parenchyma while extrahepatic CCA involves the biliary tree within the hepatoduodenal ligament. Hilar CCA are also called Klatskin tumour. The CCA incidence has increased worldwide over the last years, but there are also geographic differences, with focus in Asian countries. Known risk factors are primary sclerosing cholangitis (PSC), hepatolithiasis, Caroli's disease, hepatitis B and C infection, liver flukes, cirrhosis, diabetes, obesity, alcohol consumption and probably tobacco smoking. Patients with early CCA have only little discomfort, but can later show episodes with jaundice and other non-specific tumour symptoms. For the staging of the disease different classifications are available, which consider various factors like tumour size, location, regional lymph nodes, metastasis, vascular involvement and tumour marker.
胆管癌(CCA)是第二常见的原发性肝脏肿瘤。肝内胆管癌在肝实质内发生,而肝外胆管癌累及肝十二指肠韧带内的胆管树。肝门部胆管癌也称为克氏瘤。在过去几年中,全球胆管癌发病率有所上升,但也存在地域差异,主要集中在亚洲国家。已知的危险因素包括原发性硬化性胆管炎(PSC)、肝内胆管结石、卡罗利病、乙型和丙型肝炎感染、肝吸虫、肝硬化、糖尿病、肥胖、饮酒以及可能的吸烟。早期胆管癌患者仅有轻微不适,但后期可能会出现黄疸及其他非特异性肿瘤症状。对于该疾病的分期,有多种分类方法,这些方法考虑了肿瘤大小、位置、区域淋巴结、转移、血管受累及肿瘤标志物等各种因素。